AN ACQUEOUS PHARMACEUTICAL FORMULATION COMPRISING THE THROMBIN INHIBITOR MELAGATRAN AND USE OF THE FORMULATION IN THE MANUFACTURE OF A MEDICAMENT FOR USE BY NASAL ADMINISTRATION IN TREATING THROMBOEMBOLISM

Details for Australian Patent Application No. 2003276801 (hide)

Owner ASTRAZENECA AB

Inventors Edman, Peter; Wingstrand, Karin

Agent Davies Collison Cave

Pub. Number AU-A-2003276801

PCT Number PCT/SE03/01738

PCT Pub. Number WO2004/043486

Priority 0203349-6 12.11.02 SE

Filing date 11 November 2003

Wipo publication date 3 June 2004

International Classifications

A61K 038/55 Medicinal preparations containing peptides - Protease inhibitors

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61K 038/05 Medicinal preparations containing peptides - Dipeptides

A61K 009/00 Medicinal preparations characterised by special physical form

Event Publications

19 February 2004 Complete Application Filed

  Priority application(s): 0203349-6 12.11.02 SE

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003276801

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003276802-2-pyridone derivatives as inhibitors of neutrophile elastase

2003276800-AN ELECTRIC CONNECTION TO A CERAMIC SEALING JAW, AND A METHOD OF REALISING THE CONNECTION